Brief: Kobayashi Pharma Says Recalled Products Not Available For Sale In Mainland China Market
March 27 (Reuters) - Kobayashi Pharmaceutical Co Ltd
4967.T :
* THREE RECALLED DIETARY SUPPLEMENT PRODUCTS NOT AVAILABLE
FOR
SALE IN MAINLAND CHINA MARKET
Source text
Further company coverage: 4967.T
(Reporting by Beijing Newsroom)
((Ethan.Wang@thomsonreuters.com;))
Recent news on Kobayashi Pharmaceutical
See all newsNotice Regarding Certain Media Reports
Brief: Japan's Kobayashi Pharmaceutical Considering Going Private Under Japan-UK Investment Fund Consortium, Bloomberg News Says
Brief: Oasis Management Raises Stake In Kobayashi Pharmaceutical To 14.41% From 13.37%, Filing Shows
Table: Kobayashi Pharmaceutical - 6-MTH group results
Brief: Oasis Management Company Is Making Shareholder Proposal To Kobayashi Pharmaceutical Co, Filing Shows